The global Augmented and Virtual Reality in Healthcare market size was estimated at USD 2.3 billion in 2021 and is expected to surpass around USD 19.6 billion by 2030 and poised to grow at a compound annual growth rate (CAGR) of 26.88% during the forecast period 2022 to 2030.
Key Takeaways:
Technological advancements and digitalization in healthcare, favorable government initiatives, rising healthcare expenditure, growing usage in surgical procedures, and medical training are some of the fundamental factors anticipated to boost the growth and adoption of the augmented reality (AR) and virtual reality (VR) technologies in the healthcare industry. These technologies have wide applications in healthcare including surgeries, diagnostics, rehabilitation, training, and education.
Increasing advancements and digital disruptions in the healthcare system, rising healthcare expenditure, and the rising need for efficient and innovative solutions to enhance clinical and operational outcomes are contributing to the growth of the market. Augmented reality (AR) and virtual reality (VR) technologies are witnessing widespread adoption in surgical departments, simulation labs, education and training, and chronic pain management.
The rising number of complex surgeries is driving the demand for VR-based models to assist the surgeon. AR-based apps are used in multiple spaces such as training and education modules and patient care management tools. Innovators are receiving recognition in the form of increased investments by venture capitalists and collaboration opportunities by established players. For instance, in September 2021 OssoVR rose funding of USD 17.0 million and planned to utilize the funding towards developing virtual reality-based surgical and medical device training modules.
The hardware component segment witnessed the highest adoption owing to the rising adoption of AR and VR into different fields of healthcare. These devices range from desktops to wearable devices to display devices. Due to their audio-visual significance AR and VR is being widely adopted in education, simulation, telemedicine, and data visualization. Increasing product development in this space is contributing to market growth. For instance, in February 2019 Philips Healthcare launched a mixed reality solution by collaborating with Azurion and Microsoft. However, the services segment is expected to witness a significant CAGR during the forecast period owing to the growing need to create an immersive experience for the customer. The rising adoption in clinical trials, psychological treatment, advanced diagnostics, surgeries, and body mapping is expected to support market growth.
In addition, AR technological solutions are widely used in surgical procedures, fitness management, education and training, patient care management, medical imaging and is expected to be implemented in many more functionalities. Recent advancements in AR components have reduced the cost of augmented reality solutions and enhanced customer experience. The increasing prevalence of diseases and surgeries along with advancements in healthcare infrastructure and IT are some of the driving forces. Medical education and training using augmented reality technological solutions is also emerging rapidly and is expected to support growth. On the other hand, virtual reality technology is expected to be the fastest-growing region during the forecast period owing to the rapid integration of technology into healthcare services. VR technological solutions are widely used in telemedicine, anatomy visualization, and diagnostics. Additionally, it provides hands-on experience in medical education which is expected to contribute to market growth.
Report Scope of the Augmented and Virtual Reality in Healthcare Market
Report Coverage |
Details |
Market Size in 2022 |
USD 2.92 Billion |
Market Size by 2030 |
USD 19.6 Billion |
Growth Rate from 2022 to 2030 |
CAGR of 26.88% |
Base Year |
2021 |
Forecast Period |
2022 to 2030 |
Segments Covered |
Component, Technology, End User, Application and Geography |
Companies Mentioned |
Eon Reality, Inc, Layar, Bioflight VR, WorldViz, TheraSim Inc, CAE, GE Healthcare, Koninklijke Philips N.V., Intuitive Surgical, Siemens Ltd, Mindmaze |
Component Insights
In 2021, the hardware segment dominated the market for augmented reality and virtual reality in healthcare and accounted for the largest revenue share of 67.8%. Devices such as head-mounted displays, smart glasses, and 3D sensors hold significant shares in the market for AR & VR in healthcare. Head-mounted devices and smart glasses are widely used in training and simulation, surgeries, diagnostics, telementoring, and many applications. In the current market scenario, AR/VR hardware has a huge commercialized product base with a high rate of adoption, especially in developed countries, which can be accounted for its largest market share in 2020. Moreover, usage of single hardware in multiple applications is also one of the pivotal factors, which is expected to boost its usage and affect the market for AR and VR in healthcare.
However, the software segment is expected to grow fast over the forecast period owing to recent technological advancements in in-app designing including apps such as EyeDecide. It detects eye conditions by measuring various parameters. In addition, apps such as Applied VR help the patient overcome anxiety during any surgical procedure. In recent years, there has been a huge development in interconnectivity and network services that help patients gain access to these platforms.
Application Insights
On the basis of application, the augmented reality and virtual reality technologies are used in different fields of health care. It helps in performing the most complex surgeries and even the minimally invasive type of surgeries. The advancements in the technology and the growing demand for simplifying the medical surgeries will create more demand for augmented reality in the healthcare sector.
The domestic players and the market players in augmented reality technology have entered into partnership to increase its customer base and provide innovative products in the market. The use of this technologies has enhanced the efficiency of the healthcare sector. In the coming years the competition is expected to grow due to which the prices of these platforms will reduce. Due to the increased use of augmented reality and virtual reality inoperative procedures and visualization of anatomy the market is expected to grow well in the coming years.
Technology Insights
By technology, the augmented reality segment dominated the market for augmented reality and virtual reality in healthcare and accounted for the largest revenue share of 60.2% in 2021. Augmented reality creates a 3D view of objects and the environment around us with wearables such as head-mounted display devices and smart glasses. Factors such as technological advancements, growing demand for efficient treatment, increasing public & private investments, rising number of mergers and acquisitions, and reducing prices of head-mounted devices are among few factors that are driving the demand for augmented reality.
However, the virtual reality segment is expected to witness significant growth during the forecast years. Virtual reality enables the user to interact with a three-dimensional environment and has huge opportunities in rehabilitation and pain management. Virtual Reality exposure therapy is one such process used to treat various phobias such as fear of height, driving, claustrophobia, and posttraumatic stress disorders. Factors such as an increase in the rate of neurological disorders and rising demand for new diagnostic methods are positively driving the growth of the market.
Regional Insights
Based on region, North America dominated the augmented reality (AR) and virtual reality (VR) in the healthcare market and accounted for the largest revenue share of 40.8% in 2021. Factors that are driving growth in this region are higher adoption of these technologies, investment in R&D activities, and favorable government initiatives. The National Institute of Health of the U.S. government is offering funds for research in virtual reality with its application in healthcare. Moreover, there is a rise in outsourcing healthcare IT services in North America due to increased pressure by healthcare providers and payers to reduce treatment costs. This factor has positively impacted the growth of the market for augmented reality and virtual reality in healthcare in the region
However, Asia Pacific is expected to be the fastest-growing market over the forecast period owing to increasing awareness among the population and improving healthcare infrastructure. Developing markets such as India, China, Brazil, and Mexico are promising destinations for outsourcing services related to the development and distribution of AR and VR technologies in healthcare. Latin America, Middle East, and Asia Pacific are still at a nascent stage of development in terms of these technologies due to lack of awareness and lower adoption by the population. Countries such as Israel and UAE are witnessing increasing healthcare expenditure and quality of healthcare services, which is further expected to propel market growth in the region over the forecast period.
Some of the prominent players in the Augmented and Virtual Reality in Healthcare Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Augmented and Virtual Reality in Healthcare market
By Component
By Technology
By End User
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Points Covered in Augmented and Virtual Reality in Healthcare Market Study:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Augmented and Virtual Reality in Healthcare Market
5.1. COVID-19 Landscape: Augmented and Virtual Reality in Healthcare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Augmented and Virtual Reality in Healthcare Market, By Component
8.1. Augmented and Virtual Reality in Healthcare Market, by Component, 2022-2030
8.1.1. Hardware
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Augmented and Virtual Reality in Healthcare Market, By Technology
9.1. Augmented and Virtual Reality in Healthcare Market, by Technology e, 2022-2030
9.1.1. Augmented Reality
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Augmented Reality
9.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Augmented and Virtual Reality in Healthcare Market, By End User
10.1. Augmented and Virtual Reality in Healthcare Market, by End User, 2022-2030
10.1.1. Hospitals, Clinics, and Surgical Centers
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Research Organizations and Pharma Companies
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Research and Diagnostics Laboratories
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Government and Defense Institutions
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Augmented and Virtual Reality in Healthcare Market, By Application
11.1. Augmented and Virtual Reality in Healthcare Market, by Application, 2022-2030
11.1.1. Surgery
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Therapy
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Education and training
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Rehabilitation
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Pain management
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.5. Others
11.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Augmented and Virtual Reality in Healthcare Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.1.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.1.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.1.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.2.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.2.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.2.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.3.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.3.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.3.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.6.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.7.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.7.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.7.4. Market Revenue and Forecast, by Application (2017-2030)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Component (2017-2030)
12.4.8.2. Market Revenue and Forecast, by Technology (2017-2030)
12.4.8.3. Market Revenue and Forecast, by End User (2017-2030)
12.4.8.4. Market Revenue and Forecast, by Application (2017-2030)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.5.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.5.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.5.4. Market Revenue and Forecast, by Application (2017-2030)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Component (2017-2030)
12.5.6.2. Market Revenue and Forecast, by Technology (2017-2030)
12.5.6.3. Market Revenue and Forecast, by End User (2017-2030)
12.5.6.4. Market Revenue and Forecast, by Application (2017-2030)
Chapter 13. Company Profiles
13.1. Eon Reality, Inc
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Layar
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Bioflight VR
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. WorldViz
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. TheraSim Inc
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. CAE
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. GE Healthcare
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Koninklijke Philips N.V.
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Intuitive Surgical
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Siemens Ltd
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms